The Phase 2 obesity results have been published, and the Phase 3 programme known as TRIUMPH is ongoing and has not reported final results
Known in scientific literature as a triple-receptor agonist, Retatrutide acts simultaneously on three distinct metabolic hormone pathways: the Gastric Inhibitory Polypeptide (GIP) receptor, the Glucagon-Like Peptide-1 (GLP-1) receptor, and the Glucagon (GCG) receptor
Figure out a strategy that works for you, whether that is tracking your intake, setting a timer to remind you to drink, flavoring your water, or buying a huge Stanley cup to bring everywhere you go
Support from healthcare teams counts, as obesity will likely require long-term care, not just quick fixes
10.1161/CIRCHEARTFAILURE.108.766402